Herpes simplex virus 1 (HSV-1) and 2 (HSV-2) are doublestranded DNA viruses of the Herpesviridae family and are a common cause of cutaneous and mucocutaneous oral and genital lesions (1, 2). Historically, HSV-1 has been associated with oral lesions while HSV-2 has more often been associated with genital lesions, although recently this epidemiology has been changing. Additionally, HSV can cause invasive disease, including sepsis and fulminate encephalitis in neonates that are infected by exposure to herpetic lesions present at the time of birthing (3). Infection with HSV-1 is common, with seroprevalence reaching 50% to 70% in developed countries and Ͼ80% in developing countries (4-6). The seroprevalence of HSV-2 varies from 5% to 40% (7,8). While there is no cure for HSV infections, specific antiviral therapy exists to alleviate symptoms, shorten the duration of recurring outbreaks, and to treat life-threatening manifestations (9). Therefore, accurate laboratory diagnosis of these infections is important.The diagnosis of HSV based solely on clinical exam is difficult. Typical HSV lesions can mimic those of other sexually transmitted infectious agents (e.g., Treponema pallidum and Haemophilus ducreyi), staphylococcal folliculitis, herpes zoster, and skin abrasion due to physical injury (10). Therefore, it is essential to confirm all possible herpetic infections with laboratory diagnostics. Classically, laboratory diagnosis of superficial HSV infections relied on the collection of vesicular exudate or scrapings from a lesion and inoculation into a susceptible cell line (Hep-2, A549, etc.). Following incubation, cells are observed microscopically for viral-induced cytopathic effects (CPE) over 5 to 14 days (11). Standard cell culture was improved with the development of the enzymelinked virus-inducible system (ELVIS; Diagnostic Hybrids, Athens, OH), which increased sensitivity and reduced turnaround time (TAT) to approximately 24 h (12, 13). Overall, the sensitivity and specificity of ELVIS has been reported to range from 88% to 100% and 98% to 100%, respectively (14, 15). Importantly, the sensitivity of all culture-based diagnostics is dependent upon the presence and load of viable virus in a specimen, which is affected by the age of the lesion and specimen handling (16-18).Molecular assays include laboratory-developed and FDAcleared multiplex assays for simultaneous detection of and differ-